The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species.
Treatment and control of schistosomiasis depends on a single drug, praziquantel, but this is not ideal for several reasons including lack of potency against the juvenile stage of the parasite, dose size, and risk of resistance. We have optimised the properties of a series of compounds we discovered...
Main Authors: | J Mark F Gardner, Nuha R Mansour, Andrew S Bell, Helena Helmby, Quentin Bickle |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-07-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0009490 |
Similar Items
-
High Throughput Screening Identifies Novel Lead Compounds with Activity against Larval, Juvenile and Adult Schistosoma mansoni.
by: Nuha R Mansour, et al.
Published: (2016-04-01) -
Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening.
by: Nuha R Mansour, et al.
Published: (2010-08-01) -
In vitro efficacy of new synthetic benzimidazole-related compounds against Schistosoma mansoni adult worms
by: Amira Taman, et al.
Published: (2020-01-01) -
In vivo and in vitro studies of immune responses induced by normal or attenuated 'Schistosoma mansoni' schistosomula
by: Mansour, Nuha Ramsis Nasief
Published: (2004) -
Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial.
by: Leonore Lovis, et al.
Published: (2012-01-01)